2021

First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System

12/15/2021

VANCOUVER, British Columbia – Kardium Inc. announces the completion of successful first-in-human (FIH) procedures with the Globe Pulsed Field System. Dr. Vivek Reddy of Mount Sinai Hospital in New York, USA and Prof. Petr Neužil of Na Homolce Hospital in Prague, Czech Republic, performed the procedures in Prague last week. Dr. Jacob Koruth of Mount Sinai Hospital […]

Read More

Kardium selected as Medical/Digital Technology Company of the Year

08/05/2021

Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.

Read More

More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory

07/20/2021

Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.

Read More

B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public

01/25/2021

Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.

Read More

Kardium announces $115M in new financing for innovative atrial fibrillation treatment

01/25/2021

VANCOUVER, British Columbia – Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc. […]

Read More